Merck & Co., Inc.
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$149.52+3.19 (+2.18%)
Close on Oct 30, 2026Market cap $368.89BP/E 119.6Yield 2.19%
Merck Animal Health by Quarter
Animal Health — Livestock (cattle, poultry, swine & aqua) — Worldwide constant-currency (ex-exchange) growth YoY (%) (%)
Merck Animal Health: 6.0% in Q2 2026, down 10.0 pts from a year earlier.
Latest, Q2 2026
6.0%
Period ended Jun 30, 2026
Change on a year earlier
-10.0 pts
16.0% in Q2 2025
History
28 quarters
Since Q1 2018
Sources
28
Documents cited below
Where the Q2 2026 figure comes from
“|| Livestock | 1,064 | 1,041 | 2,105 | 924 | 961 | 1,885 | 1,023 | 987 | 3,896 | 8 | 6 | 12 | 7”
Source: Form 8-K (tm2621496d1_ex99-1.htm, filed 2026-08-04) ↗
Reported in Form 8-K Table 3 / 10-K / 10-Q MD&A.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Merck Animal Health (%), quarterly Q1 2018–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/rev-ah-livestock-ww-exfx-yoy
See every metric in the Merck KPI table. Data updated Oct 26, 2026.